We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$248M
AUM Growth
-$54.7M
Cap. Flow
-$53.1M
Cap. Flow %
-21.45%
Top 10 Hldgs %
14.37%
Holding
315
New
136
Increased
18
Reduced
93
Closed
58

Sector Composition

Rank Sector Weight
1 Healthcare 24.81%
2 Technology 18.88%
3 Industrials 12.19%
4 Consumer Discretionary 11.96%
5 Financials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRUB
126
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$707K 0.29%
9,390
-6,610
-41% -$510K
LOGM
127
DELISTED
LogMein, Inc.
LOGM
$705K 0.28%
+7,300
New +$709K
IPHI
128
DELISTED
INPHI CORPORATION
IPHI
$692K 0.28%
15,500
-28,000
-64% -$1.2M
TLGT
129
DELISTED
Teligent, Inc
TLGT
$662K 0.27%
10,015
-3,197
-24% -$225K
FET icon
130
Forum Energy Technologies
FET
$849M
$642K 0.26%
+1,459
New +$610K
SPLK
131
DELISTED
Splunk Inc
SPLK
$639K 0.26%
12,500
-5,500
-31% -$317K
ACAD icon
132
Acadia Pharmaceuticals
ACAD
$4.93B
$634K 0.26%
+22,000
New +$582K
PETX
133
DELISTED
Aratana Therapeutics, Inc.
PETX
$632K 0.26%
88,000
-120,660
-58% -$976K
AVDL
134
DELISTED
Avadel Pharmaceuticals
AVDL
$619K 0.25%
59,598
-10,460
-15% -$115K
HXL icon
135
Hexcel
HXL
$7.89B
$617K 0.25%
+12,000
New +$577K
MTCH icon
136
Match Group
MTCH
$8.9B
$599K 0.24%
35,000
-52,000
-60% -$922K
CHRS icon
137
Coherus Oncology
CHRS
$224M
$592K 0.24%
21,020
-28,540
-58% -$799K
RS icon
138
Reliance Steel & Aluminium
RS
$21.5B
$577K 0.23%
+7,260
New +$553K
KGC icon
139
Kinross Gold
KGC
$30.5B
$568K 0.23%
182,490
-153,250
-46% -$538K
B
140
Barrick Mining
B
$68.8B
$560K 0.23%
35,070
-28,530
-45% -$452K
EXAS
141
DELISTED
Exact Sciences
EXAS
$552K 0.22%
41,300
-17,590
-30% -$284K
WCG
142
DELISTED
Wellcare Health Plans, Inc.
WCG
$548K 0.22%
4,000
-10,500
-72% -$1.34M
AMZN icon
143
Amazon
AMZN
$2.94T
$525K 0.21%
14,000
-5,800
-29% -$227K
BMRN icon
144
BioMarin Pharmaceuticals
BMRN
$11.6B
$519K 0.21%
6,270
MASI
145
DELISTED
Masimo
MASI
$518K 0.21%
7,690
-6,310
-45% -$388K
CNCE
146
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$515K 0.21%
+50,000
New +$457K
ULTI
147
DELISTED
Ultimate Software Group Inc
ULTI
$512K 0.21%
2,810
+1,810
+181% +$363K
PCH
148
DELISTED
PotlatchDeltic
PCH
$500K 0.2%
+12,000
New +$484K
CMD
149
DELISTED
Cantel Medical Corporation
CMD
$492K 0.2%
+6,250
New +$486K
TSE
150
DELISTED
Trinseo
TSE
$483K 0.2%
8,150
+3,000
+58% +$168K

Similar funds

Turner Investments's Q4 2016 Portfolio in Review

As of Q4 2016, Turner Investments held 315 positions worth $248M, down 18% from $302M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Turner Investments withdrew a net $53.1M in Q4 2016, closing 58 positions and reducing 93 holdings. Its most notable exit was Aramark, an estimated $4.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Turner Investments opened a new position in Idexx Laboratories worth $3.17M.

  • Turner Investments's largest Q4 2016 buy was Idexx Laboratories: 27,000 shares worth $3.17M.
  • Turner Investments added most to bluebird bio in Q4 2016, an estimated $1.26M increase.
  • Turner Investments's biggest Q4 2016 reduction was Paramount Global Class B, cutting an estimated $5.27M.
  • Turner Investments fully exited Aramark in Q4 2016, selling an estimated $4.09M.
  • Turner Investments's ten largest holdings make up 14% of its $248M portfolio in Q4 2016.
  • Turner Investments opened 136 new positions and closed 58 in Q4 2016.
  • Turner Investments's portfolio value fell 18% quarter-over-quarter to $248M.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.